Therapeutic Advances in Endocrinology and Metabolism (May 2024)

Phenotypic characterization of nonautoimmune diabetes in adult Ugandans with low body mass index

  • Davis Kibirige,
  • Isaac Sekitoleko,
  • William Lumu,
  • Nihal Thomas,
  • Meredith Hawkins,
  • Angus G. Jones,
  • Andrew T. Hattersley,
  • Liam Smeeth,
  • Moffat J. Nyirenda

DOI
https://doi.org/10.1177/20420188241252314
Journal volume & issue
Vol. 15

Abstract

Read online

Background: Type 2 diabetes is common in relatively lean individuals in sub-Saharan Africa. It is unclear whether phenotypic differences exist between underweight and normal-weight African patients with type 2 diabetes. This study compared specific characteristics between underweight (body mass index <18.5 kg/m 2 ) and normal-weight (body mass index of 18.5–24.9 kg/m 2 ) adult Ugandans with new-onset nonautoimmune diabetes. Methods: We collected the demographic, clinical, anthropometric, and metabolic characteristics of 160 participants with nonobese new-onset type 2 diabetes (defined as diabetes diagnosed <3 months, body mass index <25 kg/m 2 , and absence of islet-cell autoimmunity). These participants were categorized as underweight and normal weight, and their phenotypic characteristics were compared. Results: Of the 160 participants with nonobese new-onset type 2 diabetes, 18 participants (11.3%) were underweight. Compared with those with normal weight, underweight participants presented with less co-existing hypertension (5.6% versus 28.2%, p = 0.04) and lower median visceral fat levels [2 (1–3) versus 6 (4–7), p < 0.001], as assessed by bioimpedance analysis. Pathophysiologically, they presented with a lower median 120-min post-glucose load C-peptide level [0.29 (0.13–0.58) versus 0.82 (0.39–1.50) nmol/l, p = 0.04] and a higher prevalence of insulin deficiency (66.7% versus 31.4%, p = 0.003). Conclusion: This study demonstrates that nonautoimmune diabetes occurs in underweight individuals in sub-Saharan Africa and is characterized by the absence of visceral adiposity, reduced late-phase insulin secretion, and greater insulin deficiency. These findings necessitate further studies to inform how the prevention, identification, and management of diabetes in such individuals can be individualized.